Clinical Trial Update: Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating vitamin K1 to slow progression of vascular calcification in hemodialysis patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Chronic Kidney Disease

Drugs mentioned

• VITAMIN K1 (PHYTONADIONE)

Snippet

Sponsor: RWTH Aachen University | Conditions: Cardiovascular Diseases | Phase 3 | Status: TERMINATED